NCT00661297View on ClinicalTrials.gov

Study Evaluating the Efficacy, Safety, and Reliability of Vardenafil

PHASE3CompletedINTERVENTIONAL

Enrollment

523

Participants

Timeline

Start Date

June 30, 2003

Study Completion Date

January 31, 2004

Conditions

Erectile Dysfunction

Interventions

DRUG

Levitra (Vardenafil, BAY38-9456)

10 mg Vardenafil to be taken 1 h prior to sexual attempt

DRUG

Placebo

Matching placebo

Sponsors

Lead Sponsor

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

Bayer

INDUSTRY

NCT00661297 - Study Evaluating the Efficacy, Safety, and Reliability of Vardenafil | Biotech Hunter | Biotech Hunter